The effect of the U.S. weight loss new drug

The effect of the U.S. weight loss new drug
U.S. Food and Drug Administration (FDA) has approved a new weight loss drugs Qsymia listed, the United States in 13 years approved diet pills can be listed in paragraph 2, Suitable for body mass index (Body Mass Index "BMI), more than 30 overweight or obese persons; clinical studies have indicated that after taking the drug, the average can lose up to 10% weight.

However, the FDA warned that the drug may affect fetal development, studies have shown that pregnant women taking Qsymia will increase the risk of fetal cleft lip and palate, pregnant women or women planning pregnancy should not take it.

In addition, taking Qsymia will increase the heart rate, may affect cardiovascular health in patients with heart disease should avoid taking does not apply, hypertension, diabetes patients, glaucoma in patients with hyperthyroidism should not take the drug.
 weight loss new drug